In current study, we focus on the oncogenic mechanism in non-small cell lung cancer patients without typical gene mutations or rearrangements/fusion and report a non-canonical role of RNase1, a human ribonuclease superfamily protein, as a ligand of wild-type ALK. This evidence concerns the gene ALK and non-small cell lung carcinoma.